Diagnosis and Nonoperative Management of Uncomplicated Jejunal Diverticulitis: A Case-Based Review
Executive Summary
Diverticular disease is a prevalent gastrointestinal condition, though it predominantly manifests in the sigmoid colon (95% of cases). Small bowel diverticulitis—specifically jejunal diverticulitis—remains a rare clinical entity, accounting for a small fraction of cases. Because its symptoms (diffuse abdominal pain, fever, and nausea) overlap significantly with more common pathologies like appendicitis and cholecystitis, it presents a significant diagnostic challenge.
Recent clinical evidence, highlighted by the case of a 48-year-old female patient, demonstrates that Computed Tomography (CT) imaging is the gold standard for rapid, accurate diagnosis. Furthermore, while surgical resection is the traditional intervention for complicated cases (perforation or abscess), uncomplicated jejunal diverticulitis can be successfully managed through nonoperative conservative measures, including intravenous antibiotics and bowel rest. Timely identification via CT is critical to preventing complications such as small bowel obstruction (SBO), gastrointestinal bleeding, and sepsis.
Overview of Diverticular Disease
Diverticulosis is defined by the protrusion of the mucosa or submucosa through weakened sections of the intestinal wall, creating sac-like bulges.
Disease Classification
The clinical spectrum of diverticular disease is categorized into two primary forms:
Uncomplicated Diverticulitis: Disease limited to the diverticula, characterized by bowel wall thickening and pericolonic inflammation. It represents approximately 88% of cases.
Complicated Diverticulitis: Characterized by secondary pathologies, including gastrointestinal bleeding, strictures, fistulas, abscess formation, peritonitis, obstruction, and perforation. This occurs in roughly 12% of cases.
Risk Factors
The pathophysiology of diverticulum formation involves a combination of genetic and environmental factors:
Lifestyle and Diet: Low-fiber diets, chronic constipation, red meat intake, tobacco use, and alcohol consumption.
Comorbidities: Hypertension and diabetes.
Microenvironment: Alterations in gut health and the intestinal microenvironment.
Epidemiology and Pathophysiology of Small Bowel Diverticula
While colonic involvement is the norm, small bowel diverticula occur with much lower frequency.
Prevalence and Distribution
Small bowel diverticular disease predominantly arises in the following locations:
Duodenum: 79% of small bowel cases (prevalence of 2–20% depending on imaging modality).
Jejunum or Ileum: 18% of small bowel cases. Jejunal diverticular disease specifically has a reported prevalence of 0.5–7%.
Mechanisms of Formation
Jejunoileal diverticula are typically located in the proximal jejunum. Their formation is linked to intestinal dysmotility and high intraluminal pressures that stress the jejunal wall, causing the mucosa and submucosa to bulge through the muscularis.
Clinical Presentation and Diagnostic Challenges
Small bowel diverticulitis is often asymptomatic and discovered incidentally. When symptomatic, its presentation is frequently nonspecific, leading to potential delays in treatment.
Common Symptoms
Mid-abdominal or epigastric pain
Fever and nausea
Bloating and early satiety
Diarrhea and steatorrhea
Leukocytosis (elevated white blood cell count)
Differential Diagnosis
The symptoms of jejunal diverticulitis overlap with several high-prevalence conditions:
Appendicitis
Cholecystitis
Gastroenteritis
Pancreatitis
Small bowel obstruction (SBO)
Small intestine bacterial overgrowth (SIBO)
The Role of Imaging
CT and Magnetic Resonance Imaging (MRI) are the only modalities capable of visualizing the complications of small bowel diverticulitis. CT imaging is considered instrumental for rapid identification, allowing clinicians to rule out other GI disorders and initiate timely intervention to reduce mortality and length of hospital stay.
Case Study: Nonoperative Management
A 48-year-old female presented with a two-day history of diffuse abdominal pain, fever, and nausea. Notably, the patient did not fit the typical demographic for this condition (median age of presentation is 73.1 years).
Clinical Findings
Laboratory Analysis: Elevated white blood cell count of 13,700 cells/µL.
CT Findings: Contrast-enhanced CT revealed:
Diffuse small bowel diverticulitis.
Mesenteric inflammation and surrounding fat stranding.
Lymph node enlargement.
Bowel wall thickening.
Treatment and Outcome
The patient was managed conservatively with intravenous (IV) normal saline and IV amoxicillin-clavulanate.
24 Hours: Fever resolved.
72 Hours: Abdominal pain, nausea, and leukocytosis resolved.
Discharge: The patient was transitioned to oral amoxicillin-clavulanate for seven days with outpatient follow-up.
Grading Severity: The Hinchey Classification
The Hinchey classification system is the standard for grading colonic diverticulitis. While no formal system exists specifically for the small bowel, the Modified Hinchey Classification is often referenced to guide management.
Table 1: Modified Hinchey Classification System
Management Strategies and Long-term Care
Treatment approaches for jejunal diverticulitis are currently adapted from colonic diverticulitis protocols.
Acute Management
Uncomplicated Cases (Hinchey IA): Managed with bowel rest, dietary changes (clear liquids), and broad-spectrum antibiotics (e.g., amoxicillin-clavulanate for gram-positive and gram-negative coverage). In some Hinchey IA cases, observation alone may be sufficient.
Abscess Formation (Hinchey IB/II): May be managed nonoperatively with antibiotics and CT-guided drainage.
Complicated Cases (Hinchey III/IV): Surgical resection of the affected small bowel is the primary treatment for perforation or peritonitis.
Outpatient and Long-term Recovery
Following the resolution of the acute phase, patients are advised to adopt lifestyle interventions to reduce the risk of recurrence:
Diet and Lifestyle: Adoption of a fiber-rich diet, weight management, tobacco cessation, and regular, vigorous physical activity.
Medication Adjustments: Avoiding non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) where possible.
Recommendations: The American Gastroenterological Association advises against the routine use of mesalamine or probiotics following an episode of acute uncomplicated diverticulitis.
